Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia see


Versions (4) ▾
  1. 12/9/13
  2. 3/25/14
  3. 4/11/14
  4. 4/11/14
Uploaded on:

April 11, 2014

No DOI assigned. To request one pleaselog in.
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00006045 AML

Eligibility AML NCT00006045

  1. StudyEvent: Eligibility
    1. Eligibility AML NCT00006045
Disease Characteristics
Patient Characteristics
Prior concurrent therapy